EphrinB2-EphB2 signaling for dendrite protection after neuronal ischemia in vivo and oxygen-glucose deprivation in vitro

• Published in: Journal of cerebral blood flow and metabolism Vol. 41; no. 7; pp. 1744 - 1755
• Main Authors: Yu, Zhanyang, Li, Wenlu, Lan, Jing, Hayakawa, Kazuhide, Ji, Xunming, Lo, Eng H, Wang, Xiaoying
• Format: Journal Article
• Language: English
• Published: London, England SAGE Publications 01.07.2021
• Subjects: Animals; Brain Ischemia - complications; Dendrites - physiology; Disease Models, Animal; Ephrin-B2 - antagonists & inhibitors; Glucose - deficiency; In Vitro Techniques; Infarction, Middle Cerebral Artery - physiopathology; Male; Mice; Mice, Inbred C57BL; Neurons - cytology; Neurons - metabolism; Original; Oxygen - metabolism; Phosphorylation; Receptor, EphB2 - antagonists & inhibitors; Signal Transduction; dendrites; ephrinB2; EphB2; oxygen-glucose deprivation; ischemia
• ISSN: 0271-678X; 1559-7016
• DOI: 10.1177/0271678X20973119

In order to rescue neuronal function, neuroprotection should be required not only for the neuron soma but also the dendrites. Here, we propose the hypothesis that ephrin-B2-EphB2 signaling may be involved in dendritic degeneration after ischemic injury. A mouse model of focal cerebral ischemia with middle cerebral artery occlusion (MCAO) method was used for EphB2 signaling test in vivo. Primary cortical neuron culture and oxygen-glucose deprivation were used to assess EphB2 signaling in vitro. siRNA and soluble ephrin-B2 ectodomain were used to block ephrin-B2-Ephb2 signaling. In the mouse model of focal cerebral ischemia and in neurons subjected to oxygen-glucose deprivation, clustering of ephrin-B2 with its receptor EphB2 was detected. Phosphorylation of EphB2 suggested activation of this signaling pathway. RNA silencing of EphB2 prevented neuronal death and preserved dendritic length. To assess therapeutic potential, we compared the soluble EphB2 ectodomain with the NMDA antagonist MK801 in neurons after oxygen-glucose deprivation. Both agents equally reduced lactate dehydrogenase release as a general marker of neurotoxicity. However, only soluble EphB2 ectodomain protected the dendrites. These findings provide a proof of concept that ephrin-B2-EphB2 signaling may represent a novel therapeutic target to protect both the neuron soma as well as dendrites against ischemic injury.